In September, the FDA approved the first hybrid closed-loop system for automating insulin delivery to reduce both highs and lows: Medtronic’s MiniMed 670G system including the latest Guardian Sensor 3 CGM. The milestone approval came after an unexpectedly fast three-month FDA review, and just four months after Medtronic reported positive data from its three-month home study.
2016: A Pivotal Year for Closed Loop/Automated Insulin Delivery
Posted in Artificial Pancreas Glucose & Insulin